NASDAQ Composite opens in less than one hour and Moderna’s premarket value is already 2.91% down.
The last session, nASDAQ Composite ended with Moderna sliding 5.33% to $123.39. NASDAQ Composite rose 0.26% to $12,804.73, following last session’s upward trend on what was a somewhat positive trend exchanging session.
Moderna’s last close was $130.34, 44.66% below its 52-week high of $178.50.
Moderna’s sales growth is 1841.7% for the current quarter and 19117.5% for the next. The company’s growth estimates for the present quarter is a negative 2.7% and positive 660% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $123.39 at 08:40 EST, way under its 52-week high of $178.50 and way higher than its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s value is above its 50-day moving average of $119.90 and way above its 200-day moving average of $81.71.